APA (7th ed.) Citation

Jesper Jørgensen, Spiros Servos, & Panos Kefalas. (2018). The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson's disease. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Jesper Jørgensen, Spiros Servos, and Panos Kefalas. The Potential Price and Access Implications of the Cost-utility and Budget Impact Methodologies Applied by NICE in England and ICER in the US for a Novel Gene Therapy in Parkinson's Disease. Taylor & Francis Group, 2018.

MLA (9th ed.) Citation

Jesper Jørgensen, et al. The Potential Price and Access Implications of the Cost-utility and Budget Impact Methodologies Applied by NICE in England and ICER in the US for a Novel Gene Therapy in Parkinson's Disease. Taylor & Francis Group, 2018.